OPTIMIZE-HF Discharge Readmission Model (OPTIMIZE-HF Readmission)

Clinical calculation support · Verify results before clinical use

Patient profile

Enter measurements from the index hospitalization.

Clinical review

Admission measurements

Comorbidities and discharge therapy

Pulmonary disease (COPD/reactive airway disease)Reported predictor in post-discharge analyses.
Documented depressionReported predictor of post-discharge mortality.
Documented liver diseaseReported predictor in post-discharge analyses.
ACE inhibitor or ARB prescribed at dischargeAssociated with lower risk in the combined outcome model; not an individual treatment-effect estimate.
Beta-blocker prescribed at dischargeAssociated with lower mortality in the reported analysis; prescribing remains individualized.
Reset form

About OPTIMIZE-HF

OPTIMIZE-HF was a hospital-based registry and quality-improvement programme for patients hospitalized with heart failure. O’Connor and colleagues analyzed follow-up outcomes in 4,402 patients, with follow-up scheduled 60–90 days after discharge in a prespecified sample.

The publication reported 60–90-day post-discharge mortality of 8.6% and rehospitalization of 29.6% in the analyzed cohort. The mortality model had a C-index of 0.74; a selected eight-factor point system for 60-day mortality had a C-index of 0.72. The combined death-or-rehospitalization model had different predictors and should not be treated as interchangeable with the mortality model.

Important distinction

The original supplied code uses custom cutoffs, point weights, and risk bands. These are not reproduced because they are not established by the cited publication. A validated individual probability requires the correct model specification and appropriate validation.

Clinical interpretation

  • Review hemodynamics, renal function, electrolytes, anemia, comorbidities, prior admissions, congestion, and overall clinical trajectory.
  • Review guideline-directed therapy for eligibility, contraindications, and tolerance; do not prescribe or withhold treatment based solely on this summary.
  • Consider medication reconciliation, timely follow-up, and transitional-care support according to clinical judgement and local pathways.
  • Do not interpret cohort event rates as an individual's predicted probability.

Reference

O’Connor CM, Abraham WT, Albert NM, et al.Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). American Heart Journal. 2008;156(4):662–673.DOI: 10.1016/j.ahj.2008.04.030 · PMID: 18926148
Disclaimer: Educational information only. This page does not calculate a validated individualized risk and must not be the sole basis for clinical decisions. Local applicability and suitability of any prediction model require separate assessment.